516
Views
25
CrossRef citations to date
0
Altmetric
Absorption–Malabsorption

Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life

, MSc, , , , , & show all
Pages 804-812 | Received 30 Dec 2008, Published online: 21 Jul 2009

References

  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–31
  • Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979–84
  • Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006; 55: 348–55
  • Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?. Gastroenterology 1999; 116: 1246–9
  • Gionchetti P., Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9
  • Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 2002; 88(Suppl 1)S67–72
  • Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10: 1802–5
  • Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, et al. Short-chain fructo-oligosaccharide administration dose-dependently increases faecal bifidobacteria in healthy humans. J Nutr 1999; 129: 112–6
  • Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108–14
  • Giannini EG, Mansi C, Dulbecco P, Savarino V. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition 2006; 22: 334–42
  • Zarling EJ, Edison T, Berger S, Leya J, DeMeo M. Effect of dietary oat and soy fiber on bowel function and clinical tolerance in a tube feeding dependent population. J Amn Coll Nutr 1994; 13: 565–8
  • Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V. Reduction in diarrhea incidence by soluble fibre in patients receiving total or supplemental enteral nutrition. J Parent Ent Nutr 1994; 18: 486–90
  • De Kruif JThCM, Vos A. The influence of soyfibre supplemented tube feeding on the occurrence of diarrhoea in postoperative patients. Clin Nutr 1993; 12: 360–4
  • Kapadia SA, Raimundo AH, Grimble GK, Aimer P, Silk DBA. Influence of three different fiber-supplemented enteral diets on bowel function and short chain fatty acid production. J Parent Ent Nutr 1995; 19: 63–8
  • Meier R, Beglinder C, Schneider H, Rowedder A, Gyr K. Effect of liquid diet with and without soluble fiber supplementation on intestinal transit and cholecystokinin release in volunteers. J Parent Ent Nutr 1993; 17: 231–5
  • Marteau P. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?. Gut 2006; 55: 1692–3
  • Harris, JA, Benedict, FG. A biometric study of basal metabolism in man. Publication no. 297. Washington, DC: Carnegie Institute of Washington; 1919.
  • Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006; 55: 348–55
  • Eypasch E, Wood-Dauphinee S, Williams JI, Ure B, Neugebauer E, Troidl H. The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg 1993; 64: 264–74
  • Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216–22
  • Agachan F, Chen T, Pfeifer J. A constipation scoring system to simplify the management of constipated patients. Dis Colon Rectum 1996; 39: 681–5
  • Huijsdens, XW. The role of the human gut microflora in inflammatory bowel disease: towards a rapid molecular quantitative analysis [Thesis]. VU University Medical Center; 2005.
  • Tannock G. Analysis of the intestinal microflora: a renaissance. Antonie van Leeuwenhoek 1999; 76: 265–78
  • Shankardass K, Chuchmach S, Chelswick K, Stefanovich C, Spurr S, Brooks J, et al. Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. J Parent Ent Nutr 1990; 14: 508–12
  • Bannerman E, Pendlebury J, Phillips F, Ghosh S. A cross-sectional and longitudinal study of health-related quality of life after percutaneous gastrostomy. Eur J Gastroenterol Hepatol 2000; 12: 1101–9
  • Schneider SM, Pouget I, Staccini P, Rampal P, Hebuterne X. Quality of life in long-term home enteral nutrition patients. Clin Nutr 2000; 19: 23–8
  • Liley AJ, Manthorpe J. The impact of home enteral tube feeding in everyday life: a qualitative study. Health Soc Care Comm 2003; 11: 415–22
  • Loeser C, von Herz U, Kuchler T, Rzehak P, Muller MJ. Quality of life and nutritional state in patients on home enteral tube feeding. Nutrition 2003; 19: 605–11
  • Schneider SM, Pouget I, Staccini P, Rampal P, Hebuterne X. Quality of life in long-term home enteral nutrition patients. Clin Nutr 2000; 19: 23–8
  • Klose J, Heldwein W, Rafferzeder M, Sernetz F, Gross M, Loeschke K. Nutritional status and quality of life in patients with percutaneous endoscopic gastrostomy (PEG) in practice: prospective one-year follow-up. Dig Dis Sci 2003; 48: 2057–63
  • Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. Gastroenterology 2007; 132: 516–26
  • Gibson GR, Beatty ER, Wang X. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 975–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.